News

A team led by researchers at Weill Cornell Medicine and the Howard Hughes Medical Institute (HHMI) Janelia Research Campus has developed and tested a high-resolution sensor for tracking the real-time dynamics of ATP levels in cells and within subcellular compartments. 

Students in the Weill Cornell Graduate School of Medical Sciences' Class of 2024 were honored for their academic achievements during its convocation ceremony on May 15.

Students from the Weill Cornell Medical College Class of 2024 were recognized for their dedication to scholarship, excellence in research, devotion to teaching and service and exceptional professional qualities on May 15 during Convocation.

In a push led by Dr. Dierdre Kelleher, the Department of Anesthesiology has joined a worldwide initiative to reduce the undesirable environmental effects of anesthetic gases.

Weill Cornell Medicine-Qatar (WCM-Q) awarded Cornell University medical degrees to 50 new doctors—the largest graduating cohort to date—at the institution’s annual graduation ceremony on May 9.

Dr. Myles Wolf, an esteemed physician-scientist who specializes in nephrology, has been appointed chair of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

A team led by Dr. Eddie Imada, assistant professor of research in pathology and laboratory medicine, has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer.

A team co-led by researchers at Weill Cornell Medicine and the New York Genome Center has developed an advanced method for revealing how gene mutations disrupt the normal packaging of DNA. 

One in six residents of assisted living facilities is subject to verbal, physical or other aggression by fellow residents in a typical month, and those suffering from dementia are most at risk, according to investigators at Cornell’s Ithaca campus and at Weill Cornell Medicine, in the first large-scale study of the phenomenon.

Inulin, a type of fiber found in certain plant-based foods and fiber supplements, causes inflammation in the gut and exacerbates inflammatory bowel disease in a preclinical model, according to a new study by Weill Cornell Medicine investigators.

Dr. Timothy Ryan, professor of biochemistry in anesthesiology at Weill Cornell Medicine, has been elected to the prestigious National Academy of Sciences, one of the highest honors a scientist can receive.

Awards, honors and achievements for the month of April. 

Early-onset heart failure is alarmingly common in urban Haiti—over 15-fold higher than previously estimated—according to a study conducted by Weill Cornell Medicine researchers in partnership with the Haitian medical organization GHESKIO.

Researchers at Weill Cornell Medicine have discovered in a preclinical model that cytokines, proteins that control immune response, circulating in maternal blood during pregnancy may mitigate an offspring's risk for psychiatric conditions.

Dr. Timothy Ryan, tri-institutional professor of biochemistry and professor of biochemistry in anesthesiology at Weill Cornell Medicine, has been elected to the American Academy of Arts and Sciences, along with two faculty members from Cornell University in Ithaca.

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.

Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study by Weill Cornell Medicine investigators.

Dr. Ashley Nelson, an assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.

Dr. Adam D. Cheriff, a physician and healthcare executive with more than 20 years of leadership experience, has been named the new chief operating officer of Weill Cornell Medicine's Physician Organization, effective May 1. 

Dr. Carl Nathan, chair of the department of microbiology and immunology and the R.A. Rees Pritchett Professor of Microbiology at Weill Cornell Medicine, answers questions about interferon-γ's history and future.